Citations (62)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Catherine J. Hutchings, Paul Colussi & Theodore G. Clark. (2019) Ion channels as therapeutic antibody targets. mAbs 11:2, pages 265-296.
Read now
Read now
Sebastian A. Andrei, Eline Sijbesma, Michael Hann, Jeremy Davis, Gavin O’Mahony, Matthew W. D. Perry, Anna Karawajczyk, Jan Eickhoff, Luc Brunsveld, Richard G. Doveston, Lech-Gustav Milroy & Christian Ottmann. (2017) Stabilization of protein-protein interactions in drug discovery. Expert Opinion on Drug Discovery 12:9, pages 925-940.
Read now
Read now
Heike Wulff & Neil A Castle. (2010) Therapeutic potential of KCa3.1 blockers: recent advances and promising trends. Expert Review of Clinical Pharmacology 3:3, pages 385-396.
Read now
Read now
Articles from other publishers (59)
Luyu Zhang, Zirong Dong, Shuai Yu, Guangyue Li, Weiwen Kong, Wenjuan Liu, Haisheng He, Yi Lu, Wei Wu & Jianping Qi. (2023) Ionic liquid-based in situ dynamically self-assembled cationic lipid nanocomplexes (CLNs) for enhanced intranasal siRNA delivery. Chinese Chemical Letters, pages 109101.
Crossref
Crossref
Miguel Olivas-Aguirre, Laura Hadit Cruz-Aguilar, Igor Pottosin & Oxana Dobrovinskaya. (2023) Reduction of Ca2+ Entry by a Specific Block of KCa3.1 Channels Optimizes Cytotoxic Activity of NK Cells against T-ALL Jurkat Cells. Cells 12:16, pages 2065.
Crossref
Crossref
Insa Thale, Sarah Maskri, Lucie Grey, Luca Matteo Todesca, Thomas Budde, Ivan Maisuls, Cristian A. Strassert, Oliver Koch, Albrecht Schwab & Bernhard Wünsch. (2022)
Imaging of K
Ca
3.1 Channels in Tumor Cells with PET and Small‐Molecule Fluorescent Probes
. ChemMedChem 18:2.
Crossref
Crossref
Peng Yan, Ben Ke & Xiangdong Fang. (2022) Ion channels as a therapeutic target for renal fibrosis. Frontiers in Physiology 13.
Crossref
Crossref
Yi Lin, Ying-Jie Zhao, Hai-Lin Zhang, Wen-Juan Hao, Ren-Di Zhu, Yan Wang, Wei Hu & Ren-Peng Zhou. (2022) Regulatory role of KCa3.1 in immune cell function and its emerging association with rheumatoid arthritis. Frontiers in Immunology 13.
Crossref
Crossref
Magdalena J. Laska, Jesper Bonnet Moeller, Jonas Heilskov Graversen, Dorte Strøbæk, Linda Blomster, Palle Christophersen & Shervin Bahrami. (2022) Retroviral glycoprotein-mediated immune suppression via the potassium channel KCa3.1 – A new strategy for amelioration of inflammatory bowel diseases. Clinical Immunology 242, pages 109081.
Crossref
Crossref
Jing Fan, Ruofei Tian, Xiangmin Yang, Hao Wang, Ying Shi, Xinyu Fan, Jiajia Zhang, Yatong Chen, Kun Zhang, Zhinan Chen & Ling Li. (2022) KCNN4 Promotes the Stemness Potentials of Liver Cancer Stem Cells by Enhancing Glucose Metabolism. International Journal of Molecular Sciences 23:13, pages 6958.
Crossref
Crossref
Cheryl L. Mathis & Amy M. Barrios. (2021) Histidine phosphorylation in metalloprotein binding sites. Journal of Inorganic Biochemistry 225, pages 111606.
Crossref
Crossref
Yaling Bai, Jinsheng Xu, Shuo Yang, Huiran Zhang, Lei He, Wei Zhou, Meijuan Cheng & Shenglei Zhang. (2021) The intermediate‐conductance calcium‐activated potassium channel KCa3.1 contributes to alkalinization‐induced vascular calcification in vitro. Journal of Clinical Laboratory Analysis 35:8.
Crossref
Crossref
Chanon Jakakul, Phongthon Kanjanasirirat & Chatchai Muanprasat. (2021) Development of a Cell-Based Assay for Identifying KCa3.1 Inhibitors Using Intestinal Epithelial Cell Lines. SLAS Discovery 26:3, pages 439-449.
Crossref
Crossref
Chunling Huang, Hao Yi, Ying Shi, Qinghua Cao, Yin Shi, Delfine Cheng, Filip Braet, Xin-Ming Chen & Carol A. Pollock. (2021) KCa3.1 Mediates Dysregulation of Mitochondrial Quality Control in Diabetic Kidney Disease. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Jialiang Wen, Bangyi Lin, Lizhi Lin, Yizuo Chen & Ouchen Wang. (2020) KCNN4 is a diagnostic and prognostic biomarker that promotes papillary thyroid cancer progression. Aging 12:16, pages 16437-16456.
Crossref
Crossref
Yan-Rong Zhu, Xiao-Xin Jiang & Dai-Min Zhang. (2019) Critical regulation of atherosclerosis by the KCa3.1 channel and the retargeting of this therapeutic target in in-stent neoatherosclerosis. Journal of Molecular Medicine 97:9, pages 1219-1229.
Crossref
Crossref
Kanin Wichapong, Hessel Poelman, Bogac Ercig, Johana Hrdinova, Xiaosong Liu, Esther Lutgens & Gerry AF Nicolaes. (2019) Rational modulator design by exploitation of protein–protein complex structures. Future Medicinal Chemistry 11:9, pages 1015-1033.
Crossref
Crossref
Giulia Torriani, Evgeniya Trofimenko, Jennifer Mayor, Chiara Fedeli, Hector Moreno, Sébastien Michel, Mathieu Heulot, Nadja Chevalier, Gert Zimmer, Neeta Shrestha, Philippe Plattet, Olivier Engler, Sylvia Rothenberger, Christian Widmann & Stefan Kunz. (2019) Identification of Clotrimazole Derivatives as Specific Inhibitors of Arenavirus Fusion. Journal of Virology 93:6.
Crossref
Crossref
Emiel P.C. van der VorstChristian Weber. (2019) Novel Features of Monocytes and Macrophages in Cardiovascular Biology and Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 39:2.
Crossref
Crossref
Giuseppe Ramirez, Lavinia Coletto, Clara Sciorati, Enrica Bozzolo, Paolo Manunta, Patrizia Rovere-Querini & Angelo Manfredi. (2018) Ion Channels and Transporters in Inflammation: Special Focus on TRP Channels and TRPC6. Cells 7:7, pages 70.
Crossref
Crossref
Salvador Valle-Reyes, Georgina Valencia-Cruz, Liliana Liñan-Rico, Igor Pottosin & Oxana Dobrovinskaya. (2018) Differential Activity of Voltage- and Ca2+-Dependent Potassium Channels in Leukemic T Cell Lines: Jurkat Cells Represent an Exceptional Case. Frontiers in Physiology 9.
Crossref
Crossref
Chunling Huang, Ling Zhang, Ying Shi, Hao Yi, Yongli Zhao, Jason Chen, Carol A. Pollock & Xin-Ming Chen. (2018) The KCa3.1 blocker TRAM34 reverses renal damage in a mouse model of established diabetic nephropathy. PLOS ONE 13:2, pages e0192800.
Crossref
Crossref
Mohammad AshrafuzzamanMohammad Ashrafuzzaman. 2018. Nanoscale Biophysics of the Cell. Nanoscale Biophysics of the Cell
293
354
.
Ruirui Lu, Cathrin Flauaus, Lea Kennel, Jonas Petersen, Oliver Drees, Wiebke Kallenborn-Gerhardt, Peter Ruth, Robert Lukowski & Achim Schmidtko. (2017) KCa3.1 channels modulate the processing of noxious chemical stimuli in mice. Neuropharmacology 125, pages 386-395.
Crossref
Crossref
Daniel Bauer, Felix Werth, Ha An Nguyen, Felix Kiecker & Jürgen Eberle. (2017) Critical role of reactive oxygen species (ROS) for synergistic enhancement of apoptosis by vemurafenib and the potassium channel inhibitor TRAM-34 in melanoma cells. Cell Death & Disease 8:2, pages e2594-e2594.
Crossref
Crossref
Rende XuChenguang LiYizhe WuLi ShenJianying MaJuying QianJunbo Ge. (2017) Role of KCa3.1 Channels in Macrophage Polarization and Its Relevance in Atherosclerotic Plaque Instability. Arteriosclerosis, Thrombosis, and Vascular Biology 37:2, pages 226-236.
Crossref
Crossref
Ilya Kovalenko, Andrea Glasauer, Laura Schöckel, Daniel R. P. Sauter, Alexander Ehrmann, Florian Sohler, Andrea Hägebarth, Ivana Novak & Sven Christian. (2016) Identification of KCa3.1 Channel as a Novel Regulator of Oxidative Phosphorylation in a Subset of Pancreatic Carcinoma Cell Lines. PLOS ONE 11:8, pages e0160658.
Crossref
Crossref
Malika Faouzi, Frederic Hague, Dirk Geerts, Anne-Sophie Ay, Marie Potier-Cartereau, Ahmed Ahidouch & Halima Ouadid-Ahidouch. (2016) Functional cooperation between KCa3.1 and TRPC1 channels in human breast cancer: Role in cell proliferation and patient prognosis. Oncotarget 7:24, pages 36419-36435.
Crossref
Crossref
Giuseppina D'Alessandro, Alfonso Grimaldi, Giuseppina Chece, Alessandra Porzia, Vincenzo Esposito, Antonio Santoro, Maurizio Salvati, Fabrizio Mainiero, Davide Ragozzino, Silvia Di Angelantonio, Heike Wulff, Myriam Catalano & Cristina Limatola. (2016) KCa3.1 channel inhibition sensitizes malignant gliomas to temozolomide treatment. Oncotarget 7:21, pages 30781-30796.
Crossref
Crossref
Susumu Ohya, Hiroaki Kito, Noriyuki Hatano & Katsuhiko Muraki. (2016) Recent advances in therapeutic strategies that focus on the regulation of ion channel expression. Pharmacology & Therapeutics 160, pages 11-43.
Crossref
Crossref
De-Li Dong, Yun-Long Bai & Ben-Zhi Cai. 2016. Ion channels as therapeutic targets, part B. Ion channels as therapeutic targets, part B
233
261
.
Petra Ehling, Manuela Cerina, Thomas Budde, Sven G. Meuth & Stefan Bittner. (2014) The CNS under pathophysiologic attack—examining the role of K2P channels. Pflügers Archiv - European Journal of Physiology 467:5, pages 959-972.
Crossref
Crossref
Chunling Huang, Carol A. Pollock & Xin-Ming Chen. (2014) Role of the potassium channel KCa3.1 in diabetic nephropathy. Clinical Science 127:7, pages 423-433.
Crossref
Crossref
Miao Zhang, Xuan-Yu Meng, Meng Cui, John M Pascal, Diomedes E Logothetis & Ji-Fang Zhang. (2014) Selective phosphorylation modulates the PIP2 sensitivity of the CaM–SK channel complex. Nature Chemical Biology 10:9, pages 753-759.
Crossref
Crossref
Susumu OhyaYuka FukuyoHiroaki KitoRina ShibaokaMiki MatsuiHiroki NigumaYasuhiro Maeda, Hisao YamamuraMasanori FujiiKazunori Kimura & Yuji Imaizumi. (2014)
Upregulation of K
Ca
3.1 K
+
channel in mesenteric lymph node CD4
+
T lymphocytes from a mouse model of dextran sodium sulfate-induced inflammatory bowel disease
. American Journal of Physiology-Gastrointestinal and Liver Physiology 306:10, pages G873-G885.
Crossref
Crossref
Lech-Gustav Milroy, Tom N. Grossmann, Sven Hennig, Luc Brunsveld & Christian Ottmann. (2014) Modulators of Protein–Protein Interactions. Chemical Reviews 114:9, pages 4695-4748.
Crossref
Crossref
Chunling Huang, Carol A. Pollock & Xin-Ming Chen. (2014) High Glucose Induces CCL20 in Proximal Tubular Cells via Activation of the KCa3.1 Channel. PLoS ONE 9:4, pages e95173.
Crossref
Crossref
C. Huang, S. Shen, Q. Ma, A. Gill, C. A. Pollock & X.-M. Chen. (2013) KCa3.1 mediates activation of fibroblasts in diabetic renal interstitial fibrosis. Nephrology Dialysis Transplantation 29:2, pages 313-324.
Crossref
Crossref
Chunling Huang, Margot L. Day, Philip Poronnik, Carol A. Pollock & Xin-Ming Chen. (2014) Inhibition of KCa3.1 suppresses TGF-?1 induced MCP-1 expression in human proximal tubular cells through Smad3, p38 and ERK1/2 signaling pathways. The International Journal of Biochemistry & Cell Biology 47, pages 1-10.
Crossref
Crossref
Rong-Guo Fu, Tao Zhang, Li Wang, Yan Du, Li-Ning Jia, Jing-Jing Hou, Gang-Lian Yao, Xiao-Dan Liu, Lei Zhang, Ling Chen, Bao-Song Gui & Rong-Liang Xue. (2014) Inhibition of the K+ Channel KCa3.1 Reduces TGF-β1-Induced Premature Senescence, Myofibroblast Phenotype Transition and Proliferation of Mesangial Cells. PLoS ONE 9:1, pages e87410.
Crossref
Crossref
Arif Burak Cekic, Etem Alhan, Arif Usta, Serdar Türkyılmaz, Birgül Vanizor Kural & Cengiz Erçin. (2013) Effects of Clotrimazol on the Acute Necrotizing Pancreatitis in Rats. Inflammation 36:6, pages 1576-1583.
Crossref
Crossref
Shyny Koshy, Danli Wu, Xueyou Hu, Rajeev B. Tajhya, Redwan Huq, Fatima S. Khan, Michael W. Pennington, Heike Wulff, Patricia Yotnda & Christine Beeton. (2013) Blocking KCa3.1 Channels Increases Tumor Cell Killing by a Subpopulation of Human Natural Killer Lymphocytes. PLoS ONE 8:10, pages e76740.
Crossref
Crossref
Stefan Bittner & Sven G. Meuth. (2013) Targeting ion channels for the treatment of autoimmune neuroinflammation. Therapeutic Advances in Neurological Disorders 6:5, pages 322-336.
Crossref
Crossref
Chunling Huang, Sylvie Shen, Qing Ma, Jason ChenAnthony GillCarol A. Pollock & Xin-Ming Chen. (2013) Blockade of KCa3.1 Ameliorates Renal Fibrosis Through the TGF-β1/Smad Pathway in Diabetic Mice. Diabetes 62:8, pages 2923-2934.
Crossref
Crossref
Susumu Ohya, Erina Nakamura, Sayuri Horiba, Hiroaki Kito, Miki Matsui, Hisao Yamamura & Yuji Imaizumi. (2013)
Role of the K
Ca
3.1 K
+
channel in auricular lymph node CD4
+
T-lymphocyte function of the delayed-type hypersensitivity model
. British Journal of Pharmacology 169:5, pages 1011-1023.
Crossref
Crossref
Dan Bi, Kazuyoshi Toyama, Vincent Lemaître, Jun Takai, Fan Fan, David P. Jenkins, Heike Wulff, David D. Gutterman, Frank Park & Hiroto Miura. (2013) The Intermediate Conductance Calcium-activated Potassium Channel KCa3.1 Regulates Vascular Smooth Muscle Cell Proliferation via Controlling Calcium-dependent Signaling. Journal of Biological Chemistry 288:22, pages 15843-15853.
Crossref
Crossref
Miao Zhang, John M. PascalJi-Fang Zhang. (2013)
Unstructured to structured transition of an intrinsically disordered protein peptide in coupling Ca
2+
-sensing and SK channel activation
. Proceedings of the National Academy of Sciences 110:12, pages 4828-4833.
Crossref
Crossref
Miao Zhang, John M. Pascal, Marcel Schumann, Roger S. Armen & Ji-Fang Zhang. (2012) Identification of the functional binding pocket for compounds targeting small-conductance Ca2+-activated potassium channels. Nature Communications 3:1.
Crossref
Crossref
Shinkyu Choi, Moon Young Kim, Ka Young Joo, Seonghee Park, Ji Aee Kim, Jae-Chul Jung, Seikwan Oh & Suk Hyo Suh. (2012) Modafinil inhibits KCa3.1 currents and muscle contraction via a cAMP-dependent mechanism. Pharmacological Research 66:1, pages 51-59.
Crossref
Crossref
Luigi Catacuzzeno, Bernard Fioretti & Fabio Franciolini. (2012) Expression and Role of the Intermediate-Conductance Calcium-Activated Potassium Channel KCa3.1 in Glioblastoma. Journal of Signal Transduction 2012, pages 1-11.
Crossref
Crossref
Zhen-hua WANG, You-ji FENG, Ju-xin ZHANG & Yue WANG. (2011) Intermediate-conductance-Ca<SUP>2+</SUP> activated K<SUP>+</SUP> channels are involved in regulating cell cycle of endometrial cancer cells. Academic Journal of Second Military Medical University 31:8, pages 864-868.
Crossref
Crossref
RE Kast, G Karpel-Massler & M-E Halatsch. (2011) Can the therapeutic effects of temozolomide be potentiated by stimulating AMP-activated protein kinase with olanzepine and metformin?. British Journal of Pharmacology 164:5, pages 1393-1396.
Crossref
Crossref
Jenny Lam & Heike Wulff. (2011) The lymphocyte potassium channels Kv1.3 and KCa3.1 as targets for immunosuppression. Drug Development Research 72:7, pages 573-584.
Crossref
Crossref
J Jehle, P A Schweizer, H A Katus & D Thomas. (2011) Novel roles for hERG K+ channels in cell proliferation and apoptosis. Cell Death & Disease 2:8, pages e193-e193.
Crossref
Crossref
N. S. Nanda Kumar, Satish K. Singh & Vazhaikkurichi M. Rajendran. (2010) Mucosal potassium efflux mediated via Kcnn4 channels provides the driving force for electrogenic anion secretion in colon. American Journal of Physiology-Gastrointestinal and Liver Physiology 299:3, pages G707-G714.
Crossref
Crossref
Nicola Sassi, Umberto De Marchi, Bernard Fioretti, Lucia Biasutto, Erich Gulbins, Fabio Franciolini, Ildikò Szabò & Mario Zoratti. (2010) An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1. Biochimica et Biophysica Acta (BBA) - Bioenergetics 1797:6-7, pages 1260-1267.
Crossref
Crossref
JW Roy, EA Cowley, J Blay & P Linsdell. (2010) The intermediate conductance Ca2+-activated K+ channel inhibitor TRAM-34 stimulates proliferation of breast cancer cells via activation of oestrogen receptors. British Journal of Pharmacology 159:3, pages 650-658.
Crossref
Crossref
P. Mene & N. Pirozzi. (2009) Potassium channels: the 'master switch' of renal fibrosis?. Nephrology Dialysis Transplantation 25:2, pages 353-355.
Crossref
Crossref
Thomas Wieland, Hans-Jörg Hippe, Katrin Ludwig, Xiao-Bo Zhou, Michael Korth & Susanne Klumpp. 2010. Methods in Enzymology: Two-Component Signaling Systems, Part C. Methods in Enzymology: Two-Component Signaling Systems, Part C
379
402
.
Susanne KlumppJosef Krieglstein. (2009) Reversible Phosphorylation of Histidine Residues in Proteins from Vertebrates. Science Signaling 2:61.
Crossref
Crossref
Line Garneau, Háléne Klein, Umberto Banderali, Ariane Longprá-Lauzon, Lucie Parent & Rámy Sauvá. (2009) Hydrophobic Interactions as Key Determinants to the KCa3.1 Channel Closed Configuration. Journal of Biological Chemistry 284:1, pages 389-403.
Crossref
Crossref
Seth L. Alper. (2008) Let's look at cysts from both sides now. Kidney International 74:6, pages 699-702.
Crossref
Crossref